Literature DB >> 3866061

Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from animal data.

J Mordenti.   

Abstract

Ceftizoxime pharmacokinetic parameters from mice, rats, monkeys, and dogs were scaled allometrically and used to predict the value of each parameter in a 70-kg human. Three methods of interspecies pharmacokinetic scale-up provided accurate simulations of the human biexponential serum concentration-time profiles for a 1-g iv bolus and a 4-g, 30-min intravenous infusion. Successful scale-up of animal pharmacokinetic data can have tremendous impact during the preclinical assessment of new pharmaceutical compounds by providing reasonable estimates of pharmacokinetic parameters in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3866061     DOI: 10.1002/jps.2600741017

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Allometric scaling of xenobiotic clearance: uncertainty versus universality.

Authors:  T M Hu; W L Hayton
Journal:  AAPS PharmSci       Date:  2001

Review 2.  Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.

Authors:  T Lavé; P Coassolo; B Reigner
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 3.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I: Interspecies allometric scaling.

Authors:  V F Cosson; E Fuseau; C Efthymiopoulos; A Bye
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

5.  Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.

Authors:  M R Feng; X Lou; R R Brown; A Hutchaleelaha
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 6.  Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

Authors:  Clara Hartmanshenn; Megerle Scherholz; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

7.  Hybrid pharmacokinetic models to describe anti-HIV nucleoside brain disposition following parent and prodrug administration in mice.

Authors:  J M Gallo; J T Etse; K J Doshi; F D Boudinot; C K Chu
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 8.  The pharmacokinetic/pharmacodynamic pipeline: translating anticancer drug pharmacology to the clinic.

Authors:  Qingyu Zhou; James M Gallo
Journal:  AAPS J       Date:  2011-01-19       Impact factor: 4.009

Review 9.  Clinical pharmacokinetics in veterinary medicine.

Authors:  J D Baggot
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

10.  Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology.

Authors:  C A Cruze; G R Kelm; M P Meredith
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.